KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Change in Account Payables (2016 - 2026)

Palvella Therapeutics has reported Change in Account Payables over the past 4 years, most recently at -$186768.0 for Q4 2017.

  • Quarterly Change in Account Payables rose 90.39% to -$186768.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was -$332000.0 through Dec 2017, down 124.41% year-over-year, with the annual reading at $1.3 million for FY2025, 43.7% down from the prior year.
  • Change in Account Payables was -$186768.0 for Q4 2017 at Palvella Therapeutics, up from -$2.1 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $3.0 million in Q3 2016 and troughed at -$2.1 million in Q3 2017.
  • The 4-year median for Change in Account Payables is $263025.0 (2017), against an average of $119431.3.
  • Year-over-year, Change in Account Payables crashed 28376.44% in 2015 and then soared 798.92% in 2017.
  • A 4-year view of Change in Account Payables shows it stood at -$3324.0 in 2014, then tumbled by 1148.41% to -$41497.0 in 2015, then plummeted by 4584.81% to -$1.9 million in 2016, then soared by 90.39% to -$186768.0 in 2017.
  • Per Business Quant, the three most recent readings for PVLA's Change in Account Payables are -$186768.0 (Q4 2017), -$2.1 million (Q3 2017), and $1.7 million (Q2 2017).